Using this strategy, we found senescent-associated markers such as CD28- and CD57+, and more broadly CD27- and CD94+, associated with GzmB expression in CD8+ T subsets from MS patients (Figure 1F). This evidence concerns the gene GZMB and myeloid sarcoma.